Screener
Biodesix, Inc. BDSX EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Biodesix, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Biodesix, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335036
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Other (expense) income: | ||||
| Interest expense | (1,982) | (1,898) | (3,959) | (3,583) |
| Change in fair value of warrant liability, net | — | 98 | — | (280) |
| Other income, net | 97 | 51 | 482 | 149 |
| Total other expense | (1,885) | (1,749) | (3,477) | (3,714) |
| Net loss | $(7,273) | $(11,468) | $(15,066) | $(22,569) |
| Net loss per share, basic and diluted(a) | $(0.71) | $(1.56) | $(1.51) | $(3.08) |
| Weighted-average shares outstanding, basic and diluted(a) | 10,296 | 7,333 | 9,977 | 7,316 |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Biodesix, Inc.'s EPS (diluted)?
- Biodesix, Inc. (BDSX) reported EPS (diluted) of -$0.71 in Q2 2026.
- How has Biodesix, Inc.'s EPS (diluted) changed year-over-year?
- Biodesix, Inc.'s EPS (diluted) increased by 54.5% year-over-year, from -$1.56 to -$0.71.
- What is the long-term trend for Biodesix, Inc.'s EPS (diluted)?
- Over 4 years (2021 to 2025), Biodesix, Inc.'s EPS (diluted) has grown at a 28.4% compound annual growth rate (CAGR), from -$1.72 to -$4.67.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Biodesix, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude